EQS-News: ABIVAX / Key word(s): Miscellaneous Abivax announces trading resumption of its ordinary shares on Euronext Paris 20.10.2023 / 15:45 CET/CEST The issuer is solely
EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Strategic Company Decision Eckert & Ziegler and Supervisory Board Decide on Investment Priorities for
Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Strategic Company Decision Eckert & Ziegler Focuses on Core Competence and Prepares Split-Off of Clinical
EQS-News: ABIVAX / Key word(s): IPO Abivax announces the pricing of its Initial Public Offering on the Nasdaq Global Market 20.10.2023 / 15:00 CET/CEST The
EQS-News: ABIVAX / Key word(s): Temporary Suspension Abivax announces temporary trading halt of its ordinary shares on Euronext Paris 20.10.2023 / 08:45 CET/CEST The issuer
EQS-News: Cantourage Group SE / Key word(s): Research Update Montega AG includes Cantourage Group SE in its coverage with ‘Buy’ 20.10.2023 / 08:10 CET/CEST The
EQS-News: PAION AG / Key word(s): Capital Increase PAION AG to issue approximately 4.8 million shares at EUR 1.90 per share in capital increase with
Over his fifty-year tenure at the Johns Hopkins School of Medicine, Dr. Griffiths dedicated years to investigating the effects of mood-altering substances, including opiates, cocaine,